Psychological Well-being, Recovery and Sexuality After Total and Subtotal Hysterectomy
Subtotal Versus Total Abdominal Hysterectomy- a Prospective Randomised Comparison of Medical , Psychological and Sexual Effects.
1 other identifier
interventional
200
1 country
7
Brief Summary
The purpose of this study is to determine whether psychological well-being, recovery and sexuality differs in women undergoing subtotal and total abdominal hysterectomy. Se also Detailed Description for additional study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Mar 1998
Longer than P75 for phase_4
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 1998
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
April 3, 2009
CompletedFirst Posted
Study publicly available on registry
April 6, 2009
CompletedJune 11, 2012
June 1, 2012
6.1 years
April 3, 2009
June 8, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychological well-being
One year after surgery
Secondary Outcomes (4)
Recovery of general well-being
Five weeks after surgery
Sexuality
One year
Pelvic organ prolapse (anatomical)
7-14 years
Patient reported symptoms of pelvic organ dysfunction
7-14 years
Study Arms (2)
TH
ACTIVE COMPARATORTotal hysterectomy
SH
ACTIVE COMPARATORSubtotal hysterectomy
Interventions
Eligibility Criteria
You may qualify if:
- Primarily uterine fibroids with bleeding disturbance or mechanical symptoms but other benign disorders were hysterectomy was recommended were also eligible
- After surgery at least one ovary preserved.
- Informed verbal and written consent
- Proficiency in Swedish
You may not qualify if:
- Malignancy in the genital organs.
- Previous or present cervical dysplasia.
- Rapidly growing fibroids where malignancy could not be ruled out
- Preoperative treatment with GnRH analogues.
- Postmenopausal women without hormone therapy
- Severe psychiatric disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Höglandssjukhuset i Eksjö
Eksjö, 57581, Sweden
Ryhov Central Hospital
Jönköping, 55185, Sweden
County Hospital in Kalmar
Kalmar, 39185, Sweden
Motala Counbty Hospital
Motala, 59185, Sweden
Vrinnevi Hospital
Norrköping, 601 82, Sweden
Capio Läkargruppen
Örebro, 70146, Sweden
Värnamo County Hospital
Värnamo, 33185, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Preben Kjölhede, MD, PhD
University Hospital, Linköping
- STUDY DIRECTOR
Pär Persson, MD
University Hospital, Linköping
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 3, 2009
First Posted
April 6, 2009
Study Start
March 1, 1998
Primary Completion
April 1, 2004
Study Completion
April 1, 2005
Last Updated
June 11, 2012
Record last verified: 2012-06